Clinical Trial Update: Stereotactic Ablative Body Radiation Therapy for Patients With Primary Renal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating stereotactic ablative body radiation therapy for patients with primary renal cell carcinoma. The current status is active but not recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Renal Cancers | Phase 2 | Status: ACTIVE_NOT_RECRUITING